Scarica l'app Stockscreener
117.14
0.13%
0.15
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AXSM Giù?
Forum
Previsione
Axsome Therapeutics Inc Borsa (AXSM) Ultime notizie
Axsome stock rating reiterated at Outperform by RBC, citing FDA flexibility - Investing.com
Vanguard Group Inc. Sells 25,537 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Wyckoff Accumulation Phase Possible in Axsome Therapeutics Inc.2025 Big Picture & Growth Focused Investment Plans - classian.co.kr
Fox Run Management L.L.C. Acquires 7,465 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics, Inc. $AXSM Shares Purchased by Invesco Ltd. - MarketBeat
Deutsche Bank AG Cuts Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Nuveen LLC Invests $48.19 Million in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Quant Tools Rank Axsome Therapeutics Inc. as High Risk High RewardJuly 2025 Technicals & Weekly High Conviction Trade Ideas - thegnnews.com
Versor Investments LP Acquires Shares of 19,615 Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics, Inc. $AXSM Shares Acquired by Charles Schwab Investment Management Inc. - MarketBeat
Axsome Therapeutics Inc. Approaches Support With Recovery in SightJuly 2025 Sector Moves & Stock Market Timing Techniques - sundaytimes.kr
What's Going On With Tonix Pharma Stock Monday?Tonix Pharmaceuticals (NASDAQ:TNXP) - Benzinga
Virtu Financial LLC Takes $931,000 Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Informed Momentum Co LLC Purchases Shares of 42,222 Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Can Axsome Therapeutics Inc. continue delivering strong returnsWeekly Profit Analysis & Fast Exit Strategy with Risk Control - thegnnews.com
Connor Clark & Lunn Investment Management Ltd. Has $20.52 Million Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
XTX Topco Ltd Sells 9,794 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Cantor Fitzgerald Has Positive View of AXSM FY2026 Earnings - MarketBeat
Equities Analysts Set Expectations for AXSM Q3 Earnings - MarketBeat
HC Wainwright Issues Negative Estimate for AXSM Earnings - MarketBeat
Cantor Fitzgerald Issues Negative Forecast for AXSM Earnings - MarketBeat
Leerink Partnrs Issues Positive Forecast for AXSM Earnings - MarketBeat
Equities Analysts Issue Forecasts for AXSM Q3 Earnings - MarketBeat
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2025 Earnings Call Transcript - MSN
Royal Bank Of Canada Raises Axsome Therapeutics (NASDAQ:AXSM) Price Target to $189.00 - MarketBeat
TD Asset Management Inc Takes Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Axsome Therapeutics' (AXSM) Buy Rating Reiterated at Needham & Company LLC - MarketBeat
Axsome outlines late-stage pipeline advancements and targets cash flow positivity amid 72% revenue growth - MSN
Axsome Therapeutics (NASDAQ:AXSM) Announces Quarterly Earnings Results, Beats Estimates By $0.08 EPS - MarketBeat
Federated Hermes Inc. Acquires Shares of 25,990 Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Axsome Therapeutics Jumps 5% as Q2 Revenue Surpasses Projections - MSN
1.55%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):